MedPath

Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.

Recruiting
Conditions
Colic, Infantile
Vomiting; Cyclical
Gastroesophageal Reflux
Constipation - Functional
Diarrhea
Dyschezia
Functional Gastrointestinal Disorders
Registration Number
NCT06031025
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

The goal of this observational study is to learn about the prevalence and characteristics of functional gastrointestinal disorders (FGID) in at risk infants (former preterm infants and those with birth asphyxia) during the first 2 years of life. The main questions it aims to answer are:

* evaluate the prevalence of symptoms related to gastro-esophageal reflux (GER), of functional gastrointestinal disorders during the first 2 years of life

* describe growth parameters during follow-up up to the corrected age of 2 years Participants will be assessed clinically and with a structured questionnaire based on the Rome IV criteria to describe FGID.

Detailed Description

Infants will undergo clinical assessment at 3, 6, 12, 24 months' corrected age at the local Follow-up clinic.

Clinical examination, anthropometric measurement and data from a structured questionnaire to detect FGID will be performed.

Z-scores for weight, length and head circumference will be calculated according to the World Health Organization (WHO) standards.

Data from the questionnaires will be collected. Clinical characteristics of patients and perinatal data will be collected and analyzed by appropriate statistical methods.

The prevalence and characteristics of FGID in the study population will be compared to published data (mostly from term infants).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
71
Inclusion Criteria
  • infants with gestational age at birth < 31 weeks
  • infants with gestational age at birth < 37 weeks and major respiratory or neurologic morbidity
  • infants with history of perinatal asphyxia
Exclusion Criteria
  • lack of informed consent
  • diagnosis of congenital or other major gastrointestinal disease (i.e. inflammatory bowel disease, cancer)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of FGID3, 6, 12, 24 months of corrected age

Occurrence of FGID (percentage of patients)

Frequency of FGID3, 6, 12, 24 months of corrected age

Frequency of FGID (i.e. number of symptoms per day)

Severity of FGID3, 6, 12, 24 months of corrected age

Severity (scales from 0 to 10 for increasing values) of FGID

Secondary Outcome Measures
NameTimeMethod
Somatic growth: weight3, 6, 12, 24 months of corrected age

Measurement of weight and calculation of z-scores based on reference standards by the World Health Organization

Somatic growth: head circumference3, 6, 12, 24 months of corrected age

Measurement of head circumference and calculation of z-scores based on reference standards by the World Health Organization

Somatic growth: length3, 6, 12, 24 months of corrected age

Measurement of length and calculation of z-scores based on reference standards by the World Health Organization

Trial Locations

Locations (1)

Fondazione Policlinico Gemelli IRCCS

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath